Kiora Pharmaceuticals Inc. (KPRX)
NASDAQ · Healthcare
Kiora Pharmaceuticals Inc. EBITDA 2015–2025
Kiora Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2018 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Kiora Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2025 was -2.3 M, a 117.62% decrease year-over-year.
- Kiora Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2025 was 7.0 M.
- Kiora Pharmaceuticals Inc. annual ebitda for 2025 was -12.8 M, a 382.73% decrease from 2024.
- Kiora Pharmaceuticals Inc. annual ebitda for 2024 was 4.5 M, a 136.13% decrease from 2023.
- Kiora Pharmaceuticals Inc. annual ebitda for 2023 was -12.5 M, a 11.67% decrease from 2021.
- Kiora Pharmaceuticals Inc. annual ebitda for 2021 was -14.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kiora Pharmaceuticals Inc. EBITDA — FAQ
Kiora Pharmaceuticals Inc. (KPRX) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KPRX's ebitda history?
The chart and table above show Kiora Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.